Siemens Healthineers-backed USARAD begins online CT scan consulting effort.
USARAD, a global teleradiology company backed by Siemens Healthineers, announced this week it will launch a first-of-its-kind screening program to identify patients with COVID-19.
This program, which will operate through USARAD’s SecondOpinions.com division, will connect radiologists to other providers. According to a company statement, chest CT-trained radiologists will provide screening diagnostics and consultations together with other medical specialists, including pulmonologists and infectious disease experts.
Launched in partnership with Medical Diagnostic Web (MDW), a blockchain-powered marketplace that provides access to hundreds of radiologists ready to provide diagnostic assistance, this new program allows providers to upload images through USARAD’s online service 24-hours-a-day. Radiologists will be on-hand to help either diagnose or rule out COVID-19, and as the volume of imaging studies increases, AI algorithms will be available to assist in decision-making.
Alongside its partnership with MDW, USARAD also announced a collaboration with the Israel-based Nanox Imaging to facilitate bringing Nanox’s mobile imaging system to high-risk areas, supporting preventive COVID-19 screening efforts in these locations.
“USARAD, together with its strategic partners, MDW and Nanox, is available to help patients world-wide during the current COVID-19 pandemic by leveraging the latest science and technology,” said Michael Yuz, M.D., USARAD founder and chief executive officer. “We are doing everything possible to reduce panic, bringing the peace of mind to millions of patients world-wide.”
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.